Sir,
We thank Drs Călugăru for their interest in our publication.1, 2 Owing to the limited number of words in our manuscript we could not provide detailed data about the study patients. We did match the groups for baseline characteristics and found no significant difference. Necessary systemic investigations were performed for the patients. 1 Electroretinography was performed at 6 months and 12 months, and we did not notice any ischemic conversion. We repeated fluorescein angiography at 6 months and at 12 months follow-up to assess the ischemia. One patient required additional laser photocoagulation at 6 months in view of visible ischemia on FFA. We did not find any neovascular complication in our study patients.
We again thank the authors for their interest.
References
Călugăru D, Călugăru M . Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'. Eye (Lond) 2016; 30: 1520–1521.
Chhablani J, Narayanan R, Mathai A, Tyagi M . Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study. Eye (Lond) 2016; 30: 1025–1027.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no conflict of interest.
Rights and permissions
About this article
Cite this article
Chhablani, J. Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study. Eye 30, 1521 (2016). https://doi.org/10.1038/eye.2016.120
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2016.120